A Bioequivalence Study of Famitinib Malate on Healthy Chinese Volunteers
Clinical trial NCT04400123 · COMPLETED
Trial details
- NCT number
- NCT04400123
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-27
- Primary completion
- 2020-07-18
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.